
SMS Pharmaceuticals Ltd is Rated Hold by MarketsMOJO
2026-11-16 10:10:35SMS Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 Nov 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 November 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read MoreSMS Pharmaceuticals Falls 2.55% Despite Technical Gains: 5 Key Factors Driving the Week
2026-11-07 17:04:15Key Events This Week Nov 2: Stock opens at ₹504.25, down 1.47% amid mixed technical momentum Nov 3: Technical momentum shifts mildly bullish; stock rebounds to ₹513.70 (+1.87%) Nov 4: SMS Pharmaceuticals hits new 52-week and all-time highs near ₹524.95; bullish technical upgrades Nov 5: Quarterly results reveal strong turnaround; stock dips 1.99% to ₹515.95 Nov 6: Profit-taking intensifies; stock closes at ₹498.70 (-3.34%) despite Sensex gains ...
Read More
SMS Pharmaceuticals Ltd is Rated Hold by MarketsMOJO
2026-11-05 10:10:03SMS Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 November 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 November 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
SMS Pharmaceuticals Ltd Reports Strong Quarterly Turnaround with Robust Revenue and Margin Expansion
2026-11-05 08:00:26SMS Pharmaceuticals Ltd has demonstrated a remarkable turnaround in its financial performance for the quarter ended September 2026, registering record highs across key metrics and prompting an upgrade in its market rating from Sell to Hold. This shift reflects a very positive financial trend, signalling renewed investor confidence in the small-cap pharmaceutical player amid a challenging industry backdrop.
Read More
Broad-Based Technical Strength Lifts SMS Pharmaceuticals Ltd to 52-Week High of Rs 524.95
2026-11-04 13:10:10With a remarkable 85.5% gain over the past year, SMS Pharmaceuticals Ltd has surged to a fresh 52-week high of Rs 524.95 on 4 Nov 2026, significantly outperforming the Sensex which declined by 7.72% over the same period. This milestone caps a sustained rally fuelled by strong technical momentum and a favourable market backdrop.
Read More
SMS Pharmaceuticals Ltd Sees Bullish Momentum Amid Technical Upgrades
2026-11-04 08:02:53SMS Pharmaceuticals Ltd has experienced a notable shift in price momentum, with technical indicators signalling a transition from a mildly bullish to a bullish trend. This change is underscored by robust weekly and monthly MACD and Bollinger Bands readings, alongside daily moving averages confirming upward momentum, positioning the small-cap pharmaceutical player for potential further gains.
Read MoreSMS Pharmaceuticals Surges 23.40% in a Week: 6 Key Drivers Behind the Rally
2026-10-31 17:02:45Key Events This Week 26 Oct: Technical momentum shifts to mildly bullish 27 Oct: Momentum upgrades to bullish with strong long-term returns 28 Oct: Intraday high surge of 7.63% amid market weakness 30 Oct: New 52-week and all-time high at Rs.499.40 and intraday peak of Rs.520 30 Oct: Week closes at Rs.511.75, +23.40% for the week Week Open ...
Read More
SMS Pharmaceuticals Ltd Surges 7.73% to Day's High of Rs 520 — Outperforms Sector by 6.09 Percentage Points
2026-10-30 11:02:04The Sensex edged up 0.15% on 30 Oct 2026, while SMS Pharmaceuticals Ltd surged 7.73%, marking a standout session with a 6.09 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This sharp intraday gain rewrites the short-term narrative for the small-cap stock, which also hit a new 52-week and all-time high of Rs 520 during the session.
Read MoreAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
10-Nov-2026 | Source : BSEEarnings Call Transcript
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
05-Nov-2026 | Source : BSEInvestors Meet Audio Recording
Announcement under Regulation 30 (LODR)-Newspaper Publication
05-Nov-2026 | Source : BSENewspaper cutting of published financial results
Corporate Actions
No Upcoming Board Meetings
SMS Pharmaceuticals Ltd has declared 40% dividend, ex-date: 22 Sep 26
SMS Pharmaceuticals Ltd has announced 1:10 stock split, ex-date: 17 Dec 15
No Bonus history available
No Rights history available
